Skip to main content
FNIH Logo
FNIH Logo
Home

Main navigation

  • Our Value
    • Advancing Biomedical Innovation
    • Why Our Work Matters
    • Our Promise
  • Our Programs
    • All Programs
    • Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
    • Accelerating Medicines Partnership® Program (AMP)
    • Awards, Prizes, and Events
    • Biomarkers Consortium
    • GeneConvene Global Collaborative
  • Our People
    • Board of Directors and Governance
    • Staff
  • Let's Collaborate
    • Advancing Research
    • Advancing Scientists
    • Advancing Our Shared Mission

Utility

  • News
    • Podcast
    • Press Releases
    • Announcements
    • Digital Timeline
  • Careers
  • Donate
Research

HIV Vaccine Development Using Virus-Like Particles

Research

PAN-TB, Project to Accelerate New Treatments for Tuberculosis

Research

Biomarkers Consortium – Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD)

Research

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML)

Research

Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM)

Research

Accelerating Medicines Partnership® Program—Common Metabolic Diseases

Research

Onchocerca Volvulus-specific Biomarkers for Bacrofilaricidal Activity (Ov Biomarkers)

Research

Research Partnership in Cognitive Aging

Research

Biomarkers Consortium - Evaluation of the Utility of Adiponectin as a Biomarker for Predicting Glycemic Efficacy

Research

Biomarkers Consortium - Carotid MRI Development and Validation via an AIMHIGH Sub-Study

Pagination

  • Page 1
  • Next page ››
Subscribe to Research

Follow Us

  • Facebook
  • Twitter
  • Youtube
  • LinkedIn

Footer

  • Privacy Policy
  • Terms of Use
  • State Nonprofit Disclosures
  • NIH
  • Financials & Annual Reports
  • Equity, Diversity and Inclusion
  • Contact

Four Stars from Charity Navigator